Ejhaem impact factor, indexing, ranking (2024)


ejhaem

Aim and Scope

The Ejhaem is a research journal that publishes research in the field of haematology, epidemiology, plasma cells, blood diseases. This journal is published by the Wiley. The ISSN of this journal is .

Also, please check the following important details about ejhaem: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: eJHaem
Publisher: Wiley
P-ISSN:
E-ISSN: 2688-6146
Language: English
Country of Publisher: United Kingdom
APC: Yes
Processing Time (Weeks): 8
Review Process: Anonymous peer review
Subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

ejhaem Indexing

The ejhaem is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Publication fee

According to journal website, the publication fee of ejhaem is around 2480 USD; 1930 GBP; 2200 EUR.

The ejhaem has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Ejhaem?

If your research is related to haematology, epidemiology, plasma cells, blood diseases, then visit the official website of ejhaem and send your manuscript.

Tips for publishing in Ejhaem:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the ejhaem publishes research articles in 8 weeks on an average.


Final Summary

  • It is published by Wiley.
  • The journal is indexed in , DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 8 weeks.
  • The Publication fee (APC) of ejhaem 2480 USD; 1930 GBP; 2200 EUR.

Sources: https://onlinelibrary.wiley.com/journal/26886146







SIMILIAR JOURNALS


ACTA ANGIOLOGICA

ISSN: 1234-950X
Publisher: VIA MEDICA

ACTA PHLEBOLOGICA

ISSN: 1593-232X
Publisher: EDIZIONI MINERVA MEDICA

AIDS RESEARCH AND TREATMENT

ISSN: 2090-1240
Publisher: HINDAWI LTD

ANGIOLOGIA

ISSN: 0003-3170
Publisher: ARAN EDICIONES, S A

ANNALS OF VASCULAR DISEASES

ISSN: 1881-641X
Publisher: ANNALS VASCULAR DISEASES EDITORIAL OFFICE

ARCHIVES OF CLINICAL INFECTIOUS DISEASES

ISSN: 2345-2641
Publisher: BRIEFLAND

ARTERIAL HYPERTENSION

ISSN: 2449-6170
Publisher: VIA MEDICA

CASE REPORTS IN INFECTIOUS DISEASES

ISSN: 2090-6625
Publisher: HINDAWI LTD

CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR

ISSN: 2666-2450
Publisher: ELSEVIER

CEREBROVASCULAR DISEASES EXTRA

ISSN: 1664-5456
Publisher: KARGER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.